BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 17572229)

  • 21. Identification of two new serum protein profiles for renal cell carcinoma.
    Engwegen JY; Mehra N; Haanen JB; Schellens JH; Voest EE; Beijnen JH
    Oncol Rep; 2009 Aug; 22(2):401-8. PubMed ID: 19578783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary matrix metalloproteinase activity is not significantly altered in patients with renal cell carcinoma.
    Cannon GM; Getzenberg RH
    Urology; 2006 Apr; 67(4):848-50. PubMed ID: 16566984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional significance of secreted Frizzled-related protein 1 in metastatic renal cell carcinomas.
    Saini S; Liu J; Yamamura S; Majid S; Kawakami K; Hirata H; Dahiya R
    Cancer Res; 2009 Sep; 69(17):6815-22. PubMed ID: 19723665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urine screening by Seldi-Tof, followed by biomarker identification, in a Brazilian cohort of patients with renal cell carcinoma (RCC).
    Alves G; Pereira DA; Sandim V; Ornellas AA; Escher N; Melle C; von Eggeling F
    Int Braz J Urol; 2013; 39(2):228-39. PubMed ID: 23683669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of novel DNA-binding proteins expressed in snake oocyte cDNA library.
    Ganesan M; Paithankar KR; Jagannadham MV; Sundaram CS; Murthy BS; Singh L
    Protein Expr Purif; 2007 May; 53(1):164-78. PubMed ID: 17189702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization and gene expression analysis of novel matched primary and metastatic renal cell carcinoma cell lines.
    Ohno Y; Izumi M; Tachibana M; Kawamura T; Yoshioka K; Aoyagi T; Ohori M; Namiki K; Sakamoto N; Nakagami Y; Hatano T; Akimoto S; Nishimura T
    Oncol Rep; 2008 Sep; 20(3):501-9. PubMed ID: 18695898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Methylation of promoter region of RASSF1A gene and frequencies of allelic imbalances in chromosome 3 critical regions are correlated with progression of clear cell renal cell carcinoma].
    Loginov VI; Khodyrev DS; Pronina IV; Kazubskaia TP; Ermilova VD; Gar'kavtseva RF; Braga EA
    Mol Biol (Mosk); 2009; 43(3):429-38. PubMed ID: 19548529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA ligand profiles of primary renal cell carcinoma maintained in metastases.
    Stickel JS; Weinzierl AO; Hillen N; Drews O; Schuler MM; Hennenlotter J; Wernet D; Müller CA; Stenzl A; Rammensee HG; Stevanović S
    Cancer Immunol Immunother; 2009 Sep; 58(9):1407-17. PubMed ID: 19184600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteomic analysis of primary cell lines identifies protein changes present in renal cell carcinoma.
    Craven RA; Stanley AJ; Hanrahan S; Dods J; Unwin R; Totty N; Harnden P; Eardley I; Selby PJ; Banks RE
    Proteomics; 2006 May; 6(9):2853-64. PubMed ID: 16596713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucose transporter-1 expression in renal cell carcinoma and its correlation with hypoxia inducible factor-1 alpha.
    Lidgren A; Bergh A; Grankvist K; Rasmuson T; Ljungberg B
    BJU Int; 2008 Feb; 101(4):480-4. PubMed ID: 17922867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential expression of nuclear matrix proteins during the differentiation of human neuroblastoma SK-N-SH cells induced by retinoic acid.
    Liang Y; Li QF; Zhang XY; Shi SL; Jing GJ
    J Cell Biochem; 2009 Apr; 106(5):849-57. PubMed ID: 19160409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD147 and VEGF expression in advanced renal cell carcinoma and their prognostic value.
    Liang YX; He HC; Han ZD; Bi XC; Dai QS; Ye YK; Qin WJ; Zeng GH; Zhu G; Xu CL; Zhong WD
    Cancer Invest; 2009 Aug; 27(7):788-93. PubMed ID: 19548138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of CD24 in clear cell renal cell carcinoma and its prognostic significance.
    Lee HJ; Kim DI; Kwak C; Ku JH; Moon KC
    Urology; 2008 Sep; 72(3):603-7. PubMed ID: 18384848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of protein alterations in male breast cancer using two dimensional gel electrophoresis and mass spectrometry: the involvement of several pathways in tumorigenesis.
    Chahed K; Kabbage M; Hamrita B; Guillier CL; Trimeche M; Remadi S; Ehret-Sabatier L; Chouchane L
    Clin Chim Acta; 2008 Feb; 388(1-2):106-14. PubMed ID: 17996735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of apoptotic tumour necrosis factor receptor-associated factor, caspase recruitment domain and cell death-inducing DFF-45 effector genes in therapy-treated renal cell carcinoma.
    Rajandram R; Pat BK; Li J; Johnson DW; Gobe GC
    Nephrology (Carlton); 2009 Apr; 14(2):205-12. PubMed ID: 19076291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of p53 isoforms in renal cell carcinoma.
    Song W; Huo SW; Lü JJ; Liu Z; Fang XL; Jin XB; Yuan MZ
    Chin Med J (Engl); 2009 Apr; 122(8):921-6. PubMed ID: 19493415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Detection of Skp2 and p27kip1 expression in human renal cell carcinoma using tissue chip technique].
    Yao C; Zheng SB; Wu P; Zhang HJ; Jiang YD; Chen T; Qi H; Zhao GZ; Zhao JF
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Apr; 28(4):642-5. PubMed ID: 18495610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of two isozymes of acyl-coenzyme A: cholesterol acyltransferase-1 and -2 in clear cell type renal cell carcinoma.
    Matsumoto K; Fujiwara Y; Nagai R; Yoshida M; Ueda S
    Int J Urol; 2008 Feb; 15(2):166-70. PubMed ID: 18269457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Screening human gastric carcinoma-associated antigens by serologic proteome analysis].
    Zeng X; Liao AJ; Tang HL; Yi L; Xie N; Su Q
    Ai Zheng; 2007 Oct; 26(10):1080-4. PubMed ID: 17927877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The potential role of purine-rich element binding protein (PUR) alpha as a novel treatment target for hormone-refractory prostate cancer.
    Inoue T; Leman ES; Yeater DB; Getzenberg RH
    Prostate; 2008 Jul; 68(10):1048-56. PubMed ID: 18386260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.